One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
Why Do You Need Chromosomal Microarray Analysis?April 4, 2023Chromosomes are genetic material and the carriers of genes. The human body has 23 pairs of chromosomes, with 22 pairs being common to both sexes and called autosomes. The other pair determines sex and...view
Development Status and Future of In Vitro Diagnostic TechnologyDecember 15, 2022In vitro diagnostic technology refers to products and services that obtain relevant clinical diagnostic information by testing samples of the body including blood, body fluids, and tissues outside the...view
Alcohol Metabolism and Its Effects on DUI Cases: Legal ImplicationsFebruary 26, 2024Driving under the influence of alcohol is a serious offense with potentially deadly consequences. As such, it is crucial for individuals to understand how alcohol metabolism can affect their blood alc...view
Concept and Application of Microarray PlatformsApril 16, 2025Concept of Microarray PlatformsA microarray platform is a high-throughput experimental platform based on miniaturization technology. It can simultaneously detect and analyze multiple biomolecules (suc...view